By contrast, incubation with the combination of trastuzumab and gastric cancer cell lines resulted in significantly upregulated CD137 expression and presentation on NK cells compared with the combination of rituximab and gastric cancer cell lines. Here, TNFRSF9 is linked to gastric cancer.